{
    "2020-08-05": [
        [
            {
                "time": "2020-08-05",
                "original_text": "恒瑞医药：SHR-1316注射液获国家药监局临床试验批",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR-1316",
                        "临床试验",
                        "国家药监局"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-08-05",
                "original_text": "北向资金8月5日成交活跃股名单抢先看",
                "features": {
                    "keywords": [
                        "北向资金",
                        "成交活跃",
                        "8月5日"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-05",
                "original_text": "疫情下差旅费仍达4.46亿？恒瑞医药上半年营收利润增速创十年新低，盈利能力下降",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "疫情",
                        "差旅费",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-08-05",
                "original_text": "国信证券医药业8月投资策略：新冠疫情肆虐，疫苗与检测主线持续",
                "features": {
                    "keywords": [
                        "国信证券",
                        "医药",
                        "新冠疫苗",
                        "检测"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-08-05",
                "original_text": "跟着牛市旗手去炒股！券商资管10大重仓股曝光",
                "features": {
                    "keywords": [
                        "牛市",
                        "券商资管",
                        "重仓股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}